Ju Fu Tang Biotech Holdings (8217) Stock Overview
An investment holding company, provides civil engineering, decoration, and renovation works in Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
8217 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
America Wants Homegrown Drones — Draganfly Is Ready to Deliver
Key Takeaways Draganfly is one of the most experienced drone manufacturers worldwide, boasting nearly three decades of innovation, and is now emerging as a North American leader in secure, NDAA-compliant drones. The company is riding massive industry tailwinds as Western governments shift away from Chinese-made drones, funneling billions into trusted domestic suppliers.Read more
Ju Fu Tang Biotech Holdings Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.32 |
| 52 Week High | HK$0.90 |
| 52 Week Low | HK$0.16 |
| Beta | 0.69 |
| 1 Month Change | 23.53% |
| 3 Month Change | 16.67% |
| 1 Year Change | 89.76% |
| 3 Year Change | 211.88% |
| 5 Year Change | -21.25% |
| Change since IPO | -99.51% |
Recent News & Updates
There Are Some Holes In Ju Fu Tang Biotech Holdings' (HKG:8217) Solid Earnings Release
Dec 05
Is WMHW Holdings (HKG:8217) Using Too Much Debt?
Dec 04Recent updates
There Are Some Holes In Ju Fu Tang Biotech Holdings' (HKG:8217) Solid Earnings Release
Dec 05Is WMHW Holdings (HKG:8217) Using Too Much Debt?
Dec 04WMHW Holdings Limited's (HKG:8217) Shares May Have Run Too Fast Too Soon
May 10More Unpleasant Surprises Could Be In Store For WMHW Holdings Limited's (HKG:8217) Shares After Tumbling 27%
Jan 26Is WMHW Holdings (HKG:8217) A Risky Investment?
Jan 10Is Luen Wong Group Holdings (HKG:8217) Weighed On By Its Debt Load?
Jun 29Is Luen Wong Group Holdings (HKG:8217) Using Debt Sensibly?
Dec 07Is Luen Wong Group Holdings (HKG:8217) Using Too Much Debt?
Aug 10Would Luen Wong Group Holdings (HKG:8217) Be Better Off With Less Debt?
Feb 27Is Luen Wong Group Holdings (HKG:8217) Using Too Much Debt?
Nov 13Does Luen Wong Group Holdings (HKG:8217) Have A Healthy Balance Sheet?
Jul 22Is Luen Wong Group Holdings (HKG:8217) A Risky Investment?
Mar 02Is Luen Wong Group Holdings (HKG:8217) Using Too Much Debt?
Nov 17Shareholder Returns
| 8217 | HK Construction | HK Market | |
|---|---|---|---|
| 7D | 14.5% | 1.8% | 0.3% |
| 1Y | 89.8% | 12.3% | 32.2% |
Return vs Industry: 8217 exceeded the Hong Kong Construction industry which returned 12.3% over the past year.
Return vs Market: 8217 exceeded the Hong Kong Market which returned 32.2% over the past year.
Price Volatility
| 8217 volatility | |
|---|---|
| 8217 Average Weekly Movement | 7.4% |
| Construction Industry Average Movement | 9.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 14.4% |
| 10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 8217 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 8217's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 22 | n/a | n/a |
Ju Fu Tang Biotech Holdings Co., Ltd, an investment holding company, provides civil engineering, decoration, and renovation works in Hong Kong. The company offers road and drainage works, which includes construction and improvement of local road and carriageway junction improvement, as well as associated footpaths, planting areas, drains, sewers, water mains, and utilities diversion services. It also provides structural works, including construction of reinforced concrete structures for bridges and retaining walls; and site formation works, such as excavation and filling works for forming a new site or later development.
Ju Fu Tang Biotech Holdings Co., Ltd Fundamentals Summary
| 8217 fundamental statistics | |
|---|---|
| Market cap | HK$95.09m |
| Earnings (TTM) | HK$20.24m |
| Revenue (TTM) | HK$27.51m |
Is 8217 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8217 income statement (TTM) | |
|---|---|
| Revenue | HK$27.51m |
| Cost of Revenue | HK$28.73m |
| Gross Profit | -HK$1.21m |
| Other Expenses | -HK$21.45m |
| Earnings | HK$20.24m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.067 |
| Gross Margin | -4.41% |
| Net Profit Margin | 73.56% |
| Debt/Equity Ratio | 29.3% |
How did 8217 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/07 12:25 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ju Fu Tang Biotech Holdings Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.